11-12 September 2018 //  Lancaster Royal Hotel, London


Tim Farries

Dr Tim Farries

Director, Regulatory Affairs, Cell & Gene Therapies, ERA Consulting

Tim Farries is “Director of Regulatory – CMC Biologics” at ERA Consulting’s London office, which provides regulatory and consultancy services to the biopharmaceutical industry.  Tim heads the core team of experts in advanced therapeutic medicinal products, which recently provided regulatory and consultancy services for the first stem cell product to be approved in the EU.  Prior to joining ERA, Tim was “Director of Scientific Projects” at Ark Therapeutics Ltd., a leading developer of virally-vectored gene therapies.  Previously he held positions managing advanced biotechnological programmes at Gendaq Limited (acquired by Sangamo Biosciences) and within Novartis Pharma.  Tim obtained his first degree, in biochemistry, from the University of Oxford, followed by completing a doctorate at the University of Cambridge.  Before embarking on his commercial career, Tim undertook a post-doctorate position at Washington University in St. Louis and then further laboratory-based research positions at the UK’s Medical Research Council laboratories in London and Cambridge.


2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad